Overview

Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy

Status:
Unknown status

Trial end date:
2014-10-01

Target enrollment:

Participant gender:

Summary

We will verify if IV injected ICG may colour breast tumors and axillary lymph nodes after neoadjuvant therapy (chemo- or hormonotherapy)

Phase:

Phase 2

Details

Lead Sponsor:

Jules Bordet Institute